Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |